![Amir Hasidim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amir Hasidim formerly worked at Beta-O2 Technologies Ltd., as Chief Executive Officer from 2021 to 2023, Quiet Therapeutics Ltd., as Director, Real-Time Radiography, Inc., as Chief Financial Officer, Tadiran Information Systems, as Principal, and JG Investments, as Principal.
Mr. Hasidim received his undergraduate degree and Masters Business Admin degree from The Hebrew University of Jerusalem.
| Unternehmen | Position | Ende |
|---|---|---|
Beta-O2 Technologies Ltd.
 Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Develops implantable bio-artificial pancreas devices | Vorstandsvorsitzender | 01.01.2023 |
Quiet Therapeutics Ltd.
 Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs | Direktor/Vorstandsmitglied | - |
Tadiran Information Systems | Corporate Officer/Principal | - |
JG Investments | Corporate Officer/Principal | - |
Real-Time Radiography, Inc.
 Real-Time Radiography, Inc. Medical SpecialtiesHealth Technology Designs and manufactures flat-panel X-ray detectors | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Real-Time Radiography, Inc.
Real-Time Radiography, Inc. Medical SpecialtiesHealth Technology Designs and manufactures flat-panel X-ray detectors | Health Technology |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta-O2 Technologies Ltd.
Beta-O2 Technologies Ltd. Medical SpecialtiesHealth Technology Develops implantable bio-artificial pancreas devices | Health Technology |
Tadiran Information Systems | |
JG Investments | |
Quiet Therapeutics Ltd.
Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
